Cargando…

Gamma rhythm low field magnetic stimulation alleviates neuropathologic changes and rescues memory and cognitive impairments in a mouse model of Alzheimer's disease

INTRODUCTION: The abnormal amyloid β (Aβ) accumulation and Aβ-related neural network dysfunction are considered central to the pathogenesis of Alzheimer's disease (AD) at the early stage. Deep-brain reachable low field magnetic stimulation (DMS), a novel noninvasive approach that was designed t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhen, Junli, Qian, Yanjing, Weng, Xiechuan, Su, Wenting, Zhang, Jianliang, Cai, Lihui, Dong, Lin, An, Haiting, Su, Ruijun, Wang, Jiang, Zheng, Yan, Wang, Xiaomin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Featured Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5671620/ https://www.ncbi.nlm.nih.gov/pubmed/29124106 http://dx.doi.org/10.1016/j.trci.2017.07.002

Ejemplares similares

Deep Brain Magnetic Stimulation Promotes Neurogenesis and Restores Cholinergic Activity in a Transgenic Mouse Model of Alzheimer’s Disease
por: Zhen, Junli, et al.
Publicado: (2017)

A Novel Immunosuppressor, (5R)-5-Hydroxytriptolide, Alleviates Movement Disorder and Neuroinflammation in a 6-OHDA Hemiparkinsonian Rat Model
por: Su, Ruijun, et al.
Publicado: (2017)

Progranulin mutations in clinical and neuropathological Alzheimer's disease
por: Vardarajan, Badri N., et al.
Publicado: (2022)

Nano‐Brake Halts Mitochondrial Dysfunction Cascade to Alleviate Neuropathology and Rescue Alzheimer's Cognitive Deficits
por: Zhang, Qian, et al.
Publicado: (2023)

Can gamma entrainment of the brain rhythms prevent or alleviate Alzheimer’s disease?
por: Kim, Tae
Publicado: (2021)

Dietary intake of branched-chain amino acids in a mouse model of Alzheimer's disease: Effects on survival, behavior, and neuropathology
por: Tournissac, Marine, et al.
Publicado: (2018)

Neuropathological lesions and their contribution to dementia and cognitive impairment in a heterogeneous clinical population
por: Godrich, Dana, et al.
Publicado: (2022)

Caspase-1 inhibition alleviates cognitive impairment and neuropathology in an Alzheimer’s disease mouse model
por: Flores, Joseph, et al.
Publicado: (2018)

Actigraphy‐estimated sleep and 24‐hour activity rhythms and the risk of dementia
por: Lysen, Thom S., et al.
Publicado: (2020)

Enhancing autophagy maturation with CCZ1-MON1A complex alleviates neuropathology and memory defects in Alzheimer disease models
por: Cai, Cui-Zan, et al.
Publicado: (2022)

Development of Written Materials for Participants in an Alzheimer's Disease and Related Dementias Screening Trial
por: Head, Katharine J, et al.
Publicado: (2022)

Complex interactions of circadian rhythms, eating behaviors, and the gastrointestinal microbiota and their potential impact on health
por: Kaczmarek, Jennifer L, et al.
Publicado: (2017)

The neuropathological diagnosis of Alzheimer’s disease
por: DeTure, Michael A., et al.
Publicado: (2019)

Managing Acute Seizures: New Rescue Delivery Option and Resources to Assist School Nurses
por: Dean, Patricia, et al.
Publicado: (2021)

ACE2 activator diminazene aceturate ameliorates Alzheimer's disease-like neuropathology and rescues cognitive impairment in SAMP8 mice
por: Duan, Rui, et al.
Publicado: (2020)

Severe Hypoglycemia and the Use of Glucagon Rescue Agents: An Observational Survey in Adults With Type 1 Diabetes
por: Hughes, Allyson S., et al.
Publicado: (2023)

Novel Balance Mechanism Participates in Stem Cell Therapy to Alleviate Neuropathology and Cognitive Impairment in Animal Models with Alzheimer’s Disease
por: Qin, Chuan, et al.
Publicado: (2021)

Baseline demographic, clinical, and cognitive characteristics of the Alzheimer's Prevention Initiative (API) Autosomal‐Dominant Alzheimer's Disease Colombia Trial
por: Rios‐Romenets, Silvia, et al.
Publicado: (2020)

Gamma Rhythms in the Brain
por: Jia, Xiaoxuan, et al.
Publicado: (2011)

Multiple comorbid neuropathologies in the setting of Alzheimer's disease neuropathology and implications for drug development
por: Rabinovici, Gil D., et al.
Publicado: (2016)

Predicting Deep Hypnotic State From Sleep Brain Rhythms Using Deep Learning: A Data-Repurposing Approach
por: Belur Nagaraj, Sunil, et al.
Publicado: (2020)

Epigenetic Modifications in Alzheimer’s Neuropathology and Therapeutics
por: Esposito, Michelle, et al.
Publicado: (2019)

Illustrated Neuropathologic Diagnosis of Alzheimer’s Disease
por: Doher, Nicholas, et al.
Publicado: (2023)

Treatment Combining Focused Ultrasound with Gastrodin Alleviates Memory Deficit and Neuropathology in an Alzheimer's Disease-Like Experimental Mouse Model
por: Luo, Kaixuan, et al.
Publicado: (2022)

Synergism of antihypertensives and cholinesterase inhibitors in Alzheimer's disease
por: Hu, Ziheng, et al.
Publicado: (2018)

Increasing brain palmitoylation rescues behavior and neuropathology in Huntington disease mice
por: Virlogeux, Amandine, et al.
Publicado: (2021)

Clinical and cognitive characteristics of preclinical Alzheimer's disease in the Japanese Alzheimer's Disease Neuroimaging Initiative cohort
por: Ihara, Ryoko, et al.
Publicado: (2018)

Contribution of Alzheimer's biomarkers and risk factors to cognitive impairment and decline across the Alzheimer's disease continuum
por: Tosun, Duygu, et al.
Publicado: (2021)

Triptolide treatment reduces Alzheimer’s disease (AD)-like pathology through inhibition of BACE1 in a transgenic mouse model of AD
por: Wang, Qi, et al.
Publicado: (2014)

Optogenetic gamma stimulation rescues memory impairments in an Alzheimer’s disease mouse model
por: Etter, Guillaume, et al.
Publicado: (2019)

The prevalence and biomarkers’ characteristic of rapidly progressive Alzheimer's disease from the Alzheimer's Disease Neuroimaging Initiative database
por: Ba, Maowen, et al.
Publicado: (2017)

Deep learning-based brain transcriptomic signatures associated with the neuropathological and clinical severity of Alzheimer’s disease
por: Wang, Qi, et al.
Publicado: (2021)

A metabolite panel that differentiates Alzheimer's disease from other dementia types
por: Jia, Longfei, et al.
Publicado: (2021)

Intranasal rifampicin for Alzheimer's disease prevention
por: Umeda, Tomohiro, et al.
Publicado: (2018)

Alzheimer's drug-development pipeline: 2016
por: Cummings, Jeffrey, et al.
Publicado: (2016)

Estrogen activates Alzheimer's disease genes
por: Ratnakumar, Abhirami, et al.
Publicado: (2019)

Animal source foods for the alleviation of double burden of malnutrition in countries undergoing nutrition transition
por: Dasi, Teena, et al.
Publicado: (2019)

Coronavirus Disease 2019 Vaccine Barriers: Educating Patients to Alleviate Fear of Receiving the Vaccine
por: Alexander, Kristin
Publicado: (2021)

Alzheimer's disease assessment scale-cognitive 11-item progression model in mild-to-moderate Alzheimer's disease trials of bapineuzumab
por: Samtani, Mahesh N., et al.
Publicado: (2015)

Granulins rescue inflammation, lysosome dysfunction, and neuropathology in a mouse model of progranulin deficiency
por: Root, Jessica, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2gv5nvjc58j356l1m37c2fqtlv